Compare OPCH & KBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OPCH | KBR |
|---|---|---|
| Founded | N/A | 1901 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 4.8B |
| IPO Year | 1996 | 2006 |
| Metric | OPCH | KBR |
|---|---|---|
| Price | $29.04 | $36.55 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 8 |
| Target Price | $37.00 | ★ $53.14 |
| AVG Volume (30 Days) | ★ 1.5M | 1.2M |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 1.76% |
| EPS Growth | 3.25 | ★ 15.05 |
| EPS | 1.27 | ★ 3.21 |
| Revenue | $4,998,202,000.00 | ★ $5,767,000,000.00 |
| Revenue This Year | $7.21 | $4.56 |
| Revenue Next Year | $8.55 | $5.11 |
| P/E Ratio | $23.18 | ★ $11.68 |
| Revenue Growth | ★ 16.17 | 2.27 |
| 52 Week Low | $24.24 | $35.62 |
| 52 Week High | $36.80 | $56.78 |
| Indicator | OPCH | KBR |
|---|---|---|
| Relative Strength Index (RSI) | 49.06 | 39.71 |
| Support Level | $27.48 | $35.91 |
| Resistance Level | $30.55 | $38.34 |
| Average True Range (ATR) | 0.78 | 1.18 |
| MACD | 0.37 | 0.17 |
| Stochastic Oscillator | 79.79 | 20.36 |
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.
KBR, formerly Kellogg Brown & Root, is a global provider of technology, integrated engineering, procurement, and construction delivery, and operations and maintenance services. The company's business is organized into two segments: mission technology solutions and sustainable technology solutions. KBR has operations in over 30 countries and employs approximately 36,000 people. The firm generated $7.8 billion in revenue in 2025.